Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516473 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Search Results

Your Search for 'Commercial Insight: Infectious Diseases Overview' returned 31 results - Page 1 of 2

  Sort by   
  Sorted by Rank Top-Bottom

Innovations in Combating Infectious Diseases: Opportunities in Therapeutics and Diagnostics through Application of Proteomics, Genomics, Nanotechnology, and Novel Sources of Lead Generation  
Business Insights, June 2010, Pages: 250
disease Report scope Chapter 2 Proteomics in the design of novel diagnostics for infectious diseases Summary Introduction An overview of techniques in proteomics Separation techniques Two


Novel Antibodies & Therapeutic Proteins: Technological Challenges & Future Prospects  
PharmaVision, Aug 2010, Pages: 183
- Alzheimer's disease - Infectious diseases - Bacterial infections - Pain - Ones to Watch: Companies - Amgen - Bioinvent International AB - Celdex Therapeutics Inc - Genmab A/S - Glycotope GmbH


Molecular Diagnostics - Global Strategic Business Report  
Global Industry Analysts, Inc., Oct 2010, Pages: 659
Infectious Diseases Testing 4 Pharmacogenomics 4 Cancer Screening 4 2. INDUSTRY OVERVIEW 5 Global Market Outlook 5 Molecular Diagnostics - The Fastest Growing Medical Diagnostic Technology 5 Current


Stakeholder Opinions: Tropical Diseases - Dengue, Japanese encephalitis and West Nile virus - Increasing attention for neglected diseases  
Datamonitor, Dec 2010, Pages: 204
major markets and its impact on commercial opportunities Overview Catalyst Summary About Datamonitor healthcare About the Infectious Disease pharmaceutical analysis team Executive Summary Scope of


Nanotechnology - Global Outlook  
Global Industry Analysts, Inc., Jan 2012, Pages: 173
Nervous System and Orthopedics, Infectious Diseases, Cardiovascular Diseases and Others 36 Transportation 37 Aerospace and Defense 37 Defying Gravity- NASA Banks on Nanotechnology 38 Nanobiotechnology


Point of Care Testing: Evaluating the Return to Evidence Based Medicine, Novel Technologies and the Competitive Landscape  
Business Insights, Jan 2010, Pages: 283
; hemostasis; cardiology; infectious disease; drugs of abuse; automated urine/blood analysis; and cancer screening. - Surveys analytes/biomarkers incorporated in commercial POCT products on the market and in


Stakeholder Opinions: Biologics in Infectious Diseases - Well Defined Target Populations are Key to Commercial Success  
Datamonitor, March 2008, Pages: 123
EXECUTIVE SUMMARY 3 Scope of the analysis 3 Datamonitor insight into biologics infectious diseases 3 Contributing experts 6 Related reports 6 Upcoming related reports 7 CHAPTER 2 COMMERCIAL OUTLOOK 9 Unmet


Stakeholder Insight: Hepatitis B & C in Asia - China, South Korea, Taiwan and Turkey  
Datamonitor, Feb 2010, Pages: 35
Turkey BIBLIOGRAPHY Journal papers Websites Other About the Infectious Diseases analysis team Disclaimer


Outlook for RNAi, 2007: siRNA and miRNA in Biology, Diagnostics and Therapeutics  
Business Insights, June 2007, Pages: 244
inareas such as cancer and infectious diseases. Since 2005, enormous strides have also been made in the development of RNAi-based therapeutic products, bringing them significantly closer to the market


Stakeholder Opinions: Sexually Transmitted Diseases - An Underestimated Threat Lacking Interventions to Prevent Transmission  
Datamonitor, Aug 2010, Pages: 142
advantage by identifying key product characteristics and potential roles for new therapies Overview Catalyst Summary About Datamonitor healthcare About the Vaccines & Infectious Diseases pharmaceutical


Biotechnology Industry 2010 Yearbook - Top Biologics, Biosimilars, Licensing and Financing, Mergers and Acquisitions  
GBI Research, Dec 2010, Pages: 198
therapeutics, such as oncology, infectious diseases including HIV, and autoimmune disorders. A strong product pipeline for most of the top 10 biotechnology companies will result in a continuation of this growth


Infectious Diseases Vaccine Market Overview  
Datamonitor, Oct 2010, Pages: 196
Infectious Diseases Vaccine Market Overview Introduction Long being regarded as an unattractive market, vaccines have re-emerged as successful growth driver for Big Pharma. The launch and rapid


Emerging Medical Technologies Spotlight, a Report of Investment & Partnering Opportunities 2010  
Life Science Intelligence, Jan 2011
diagnostic assays for infectious diseases, with an initial focus on hospital-acquired infections - Effective antimicrobial coatings and compounds that are broad-spectrum and fast-acting against clinically


Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity  
Datamonitor, May 2010, Pages: 108
advantage by identifying key HIV players, product characteristics and potential roles for new therapies Overview Catalyst Summary Executive Summary Scope of the analysis Datamonitor insight into the


Quintiles Transnational Corp.: Company Profile and SWOT Analysis  
iCD Research, Sep 2011, Pages: 31
infectious diseases. It has presence in 60 countries across North America and Central America, South America, Europe, Asia, Africa, and Australia and New Zealand. Quintiles is headquartered in Durham, North


Quintiles Transnational Corp.: Pharmaceuticals and Healthcare Company profile & SWOT Report  
iCD Research, Feb 2012, Pages: 27
focuses principally on the fields of diabetes, pediatrics, women's health, internal medicine, cardiovascular, central nervous system, oncology, and infectious diseases. It has presence in 60 countries


Drug Delivery Technologies: Players, products & prospects to 2018  
Espicom Business Intelligence Ltd, June 2009, Pages: 472
commercial executives to get a balanced and independent overview of the competitive landscape. That is why this major new 4-volume report, Drug Delivery Technologies: Players, Products and Prospects to 2018


bioMerieux S.A. (BIM) - Financial and Strategic SWOT Analysis Review  
GlobalData, May 2011, Pages: 50
. It offers diagnostic solutions such as instruments, reagents and software. The company's products are used in diagnosing infectious diseases and provide high medical value results in cancer screening


Vical Incorporated (VICL) - Financial and Strategic SWOT Analysis Review  
GlobalData, Aug 2011, Pages: 44
-threatening diseases. The company also focused on development of vaccine for certain infectious diseases, such as H1N1, herpes simplex virus disease and cancer. The company also provides products, which


Vaccines Market Insight: Products, Pipelines & Market Outlook  
Informa Healthcare, Jan 2007, Pages: 175
needs 66 3.2.1 Cancer 66 3.2.2 HIV/AIDS 66 3.2.3 Autoimmune diseases 67 3.2.3.1 Asthma 67 3.2.3.2 Diabetes mellitus (type 1) 67 3.2.3.3 Rheumatoid arthritis (RA) 67 3.2.4 Infectious disease 68 3.2.4.1


Results:  First -   Prev -   1 -   2 -   Next -   Last


For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds